457 related articles for article (PubMed ID: 21821321)
1. Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
Chen H; Zuo S; Wang X; Tang X; Zhao M; Lu Y; Chen L; Liu J; Liu Y; Liu D; Zhang S; Li T
Eur J Med Chem; 2011 Sep; 46(9):4709-14. PubMed ID: 21821321
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
4. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
Zilla MK; Nayak D; Vishwakarma RA; Sharma PR; Goswami A; Ali A
Eur J Med Chem; 2014 Apr; 77():47-55. PubMed ID: 24607588
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
[TBL] [Abstract][Full Text] [Related]
6. Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents.
Bhat BA; Reddy PB; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Eur J Med Chem; 2008 Oct; 43(10):2067-72. PubMed ID: 17988764
[TBL] [Abstract][Full Text] [Related]
7. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of derivatives of 4-deoxypodophyllotoxin as antitumor agents.
Jin Y; Liu J; Huang WT; Chen SW; Hui L
Eur J Med Chem; 2011 Sep; 46(9):4056-61. PubMed ID: 21733601
[TBL] [Abstract][Full Text] [Related]
9. Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells.
Chen J; Ma L; Zhang R; Tang J; Lai H; Wang J; Wang G; Xu Q; Chen T; Peng F; Qiu J; Liang X; Cao D; Ran Y; Peng A; Wei Y; Chen L
Arch Pharm (Weinheim); 2012 Dec; 345(12):945-56. PubMed ID: 22949330
[TBL] [Abstract][Full Text] [Related]
10. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
Shi C; Wang J; Chen H; Shi D
J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells.
Guo YE; Chen H; Zuo S; Liu DL; Lu YL; Lv JJ; Wen SP; Zhang TC
J Asian Nat Prod Res; 2011 May; 13(5):417-24. PubMed ID: 21534039
[TBL] [Abstract][Full Text] [Related]
12. Solvent effect on copper-catalyzed azide-alkyne cycloaddition (CuAAC): synthesis of novel triazolyl substituted quinolines as potential anticancer agents.
Ellanki AR; Islam A; Rama VS; Pulipati RP; Rambabu D; Krishna GR; Reddy CM; Mukkanti K; Vanaja GR; Kalle AM; Kumar KS; Pal M
Bioorg Med Chem Lett; 2012 May; 22(10):3455-9. PubMed ID: 22516283
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
[TBL] [Abstract][Full Text] [Related]
14. Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry.
Imperio D; Pirali T; Galli U; Pagliai F; Cafici L; Canonico PL; Sorba G; Genazzani AA; Tron GC
Bioorg Med Chem; 2007 Nov; 15(21):6748-57. PubMed ID: 17765552
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.
Zi CT; Liu ZH; Li GT; Li Y; Zhou J; Ding ZT; Hu JM; Jiang ZH
Molecules; 2015 Feb; 20(2):3255-80. PubMed ID: 25690288
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
Chen SW; Tian X; Tu YQ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
Cheng WH; Cao B; Shang H; Niu C; Zhang LM; Zhang ZH; Tian DL; Zhang S; Chen H; Zou ZM
Eur J Med Chem; 2014 Oct; 85():498-507. PubMed ID: 25113878
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
Yang L; Liu YQ; Tan H; Li WG; Tian X
Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
[TBL] [Abstract][Full Text] [Related]
19. An efficient one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives as anti-cancer agents.
Yan SJ; Liu YJ; Chen YL; Liu L; Lin J
Bioorg Med Chem Lett; 2010 Sep; 20(17):5225-8. PubMed ID: 20655212
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
